Immune boosting by B. 1.1. 529 (Omicron) depends on previous SARS-CoV-2 exposure
The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided
with the spread of variants of concern. We investigated whether single-dose vaccination, …
with the spread of variants of concern. We investigated whether single-dose vaccination, …
[HTML][HTML] Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
do not necessarily develop PCR or antibody positivity, suggesting that some …
do not necessarily develop PCR or antibody positivity, suggesting that some …
[HTML][HTML] Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
…, B Willems, MJ Zekveld, H Dreja, E O'Sullivan, C Pade… - PloS one, 2010 - journals.plos.org
Background The isolation of human monoclonal antibodies (mAbs) that neutralize a broad
spectrum of primary HIV-1 isolates and the characterization of the human neutralizing …
spectrum of primary HIV-1 isolates and the characterization of the human neutralizing …
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
CJ Reynolds, L Swadling, JM Gibbons, C Pade… - Science …, 2020 - science.org
Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
CJ Reynolds, JM Gibbons, C Pade, KM Lin… - Science, 2022 - science.org
The impact of the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infecting strain on downstream immunity to heterologous variants of concern (VOCs) is unknown…
infecting strain on downstream immunity to heterologous variants of concern (VOCs) is unknown…
[HTML][HTML] A whole genome screen for HIV restriction factors
L Liu, NMM Oliveira, KM Cheney, C Pade, H Dreja… - Retrovirology, 2011 - Springer
Background Upon cellular entry retroviruses must avoid innate restriction factors produced
by the host cell. For human immunodeficiency virus (HIV) human restriction factors, …
by the host cell. For human immunodeficiency virus (HIV) human restriction factors, …
[HTML][HTML] Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
…, G Joy, AD Otter, JM Gibbons, C Pade… - Nature …, 2023 - nature.com
Among the unknowns in decoding the pathogenesis of SARS-CoV-2 persistent symptoms in
Long Covid is whether there is a contributory role of abnormal immunity during acute …
Long Covid is whether there is a contributory role of abnormal immunity during acute …
[HTML][HTML] Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy …
Background We hypothesised that host-response biomarkers of viral infections might
contribute to early identification of individuals infected with SARS-CoV-2, which is critical to …
contribute to early identification of individuals infected with SARS-CoV-2, which is critical to …
[PDF][PDF] Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
…, A Woolston, T Ronel, C Pade… - Cell Reports …, 2022 - cell.com
Effective control of SARS-CoV-2 infection on primary exposure may reveal correlates of
protective immunity to future variants, but we lack insights into immune responses before or at …
protective immunity to future variants, but we lack insights into immune responses before or at …
